PFE
PFE
Pfizer Inc.
$25.84
-$0.12 (-0.48%)
Mkt Cap: $147.25B
Home / PFE / Financial Statements

Pfizer Inc. (PFE) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$63.31B
$62.58B ↓1.6%
$63.63B ↑6.8%
$59.55B ↓40.6%
$100.33B ↑23.4%
$81.29B
Cost of Revenue
$19.41B
$18.57B ↓14.8%
$21.78B ↓25.4%
$29.21B ↓23.6%
$38.24B ↑11.1%
$34.41B
Gross Profit
$43.91B
$44.01B ↑5.2%
$41.85B ↑37.9%
$30.34B ↓51.1%
$62.09B ↑32.5%
$46.88B
R&D Expenses
$12.42B
$11.98B ↑11.5%
$10.74B ↑1.5%
$10.58B ↓7.4%
$11.43B ↓17.4%
$13.83B
SG&A Expenses
$13.28B
$13.35B ↓9.4%
$14.73B ↑1.8%
$14.47B ↑10.3%
$13.12B ↑7.0%
$12.25B
Operating Income
$14.85B
$15.44B ↓6.3%
$16.48B ↑211.5%
$5.29B ↓85.9%
$37.55B ↑80.6%
$20.79B
Interest Expense
$2.69B
$2.67B ↓13.6%
$3.09B ↑39.9%
$2.21B ↑78.4%
$1.24B ↓4.1%
$1.29B
Income Tax
$384.00M
-$266.00M ↓850.0%
-$28.00M ↑97.5%
-$1.11B ↓133.5%
$3.33B ↑79.7%
$1.85B
Net Income
$7.49B
$7.77B ↓3.1%
$8.02B ↑276.0%
$2.13B ↓93.2%
$31.36B ↑41.6%
$22.15B
EBITDA
$16.94B
$15.10B ↓16.7%
$18.13B ↑89.7%
$9.56B ↓76.7%
$41.03B ↑33.2%
$30.79B
EPS
1.31
1.36 ↓3.5%
1.41 ↑279.8%
0.37 ↓93.2%
5.47 ↑41.0%
3.88
Shares Out (Diluted)
22.84B
5.69B ↓0.2%
5.70B ↓0.2%
5.71B ↓0.4%
5.73B ↑0.4%
5.71B